Alzheimer’s disease (AD) is a complex progressive neurodegenerative disease characterized by the accumulation of Aβ plaques and tau NFTs, which are considered to result in neuronal loss and cognitive decline. This slide deck discusses neurobiology and aetiology for AD and highlights topics as risk factors, pathopsysiological hypotheses, and the development and importance of biomarkers.

This slide deck has been developed by Joseph Therriault, PhD, McGill University, Montréal, Québec, Canada; and Professor Serge Gauthier, McGill University, Montréal, Québec, Canada, in collaboration with Cambridge Medical – A Prime Global agency.

Index for
slide deck

Introduction

AD-Neurobiology & Aetiology slide1
Neurobiology and aetiology
file_download Download slide
AD-Neurobiology & Aetiology slide2
Alzheimer’s disease research timeline

Diagnosis of AD has developed from a pathological approach to a more clinical and exclusionary approach.1,3 NIA-AA Criteria published in 2011, combined with a clinical and biological approach developed by the International Working Group (IWG), allowed for the emergence o…

file_download Download slide
AD-Neurobiology & Aetiology slide3
Alzheimer’s disease is not synonymous with dementia

References on slide:
1.Alzheimer's Disease International website. Dementia facts and figures. Available at: https://www.alzint.org/about/dementia-facts-figures/. Accessed 1 June 2023.

2.Alzheimer's Association website. What is dementia? Available at: https://www.alz.or…

file_download Download slide
AD-Neurobiology & Aetiology slide5
What is neurodegeneration?

Aβ and tau pathology in AD results in neuroinflammation, mitochondrial dysfunction, metabolic dysregulation, and protein deficiency.1 The resulting neurotoxicity and disturbed neuroplasticity that occur lead to neurodegeneration.1 In vivo, neurodegeneration in AD is iden…

file_download Download slide

Risk factors

AD-Neurobiology & Aetiology slide6
Risk factors
file_download Download slide
AD-Neurobiology & Aetiology slide7
What factors are at play in Alzheimer’s disease?

While the most prominent risk factor for AD is increasing age, the disease develops as a result of several risk factors that converge.2 Environmental factors such as traumatic brain injury, ischemia, hypoxia, neurotoxins, infections, lifestyle, metabolic parameters, and …

file_download Download slide
AD-Neurobiology & Aetiology slide8
Genetic risk factors

The estimated heritability of AD is approximately 70%, and does not differ between sex.1,9 To date, 75 risk loci have been identified for AD and related dementias.8 Several studies in multiple ethnic groups have associated the APOE gene with familial-AD and sporadic late…

file_download Download slide
AD-Neurobiology & Aetiology slide10
Modifiable lifestyle factors and prevention strategies

AD has a long prodromal phase, during which early prevention is important to slow progression of the disease.1 Psychosocial factors such as educational attainment and bilingualism work to enhance cognitive activity, processing, and intellectual capacities.1,3 Regular soc…

file_download Download slide
AD-Neurobiology & Aetiology slide11
Accumulation of dementia risk factors over time

Maintaining good physical health in individuals with dementia is important for cognition.1 In early life (i.e., <45 years), lack of education has been associated with an increased risk of dementia.1 In middle life (i.e., 45–65 years), and not necessarily in later life (i…

file_download Download slide

Related content

image Image Studying Cognitive Impairment and its Neuronal Underpinnings to Predict Illness Prognosis in Bipolar Disorder
Studying Cognitive Impairment and its Neuronal Underpinnings to Predict Illness Prognosis in Bipolar Disorder

To study intra-disease variability in cognitive function, researchers employ data-driven clustering methods to differentiate patients with widespread cognitive abnormalities from patients who are cognitively intact.

05.02.2024 Mental Health
image Image The Clinical Heterogeneity in Bipolar Disorder within Several Domains.
The Clinical Heterogeneity in Bipolar Disorder within Several Domains

Bipolar disorder is associated with marked clinical and phenotypic heterogeneity, including differences in symptomatology, medical and psychiatric comorbidities, and neurocognitive function. Intra- and inter-individual differences increase the complexity of the disorder, which complicates accurate diagnosis, management.

05.02.2024 Mental Health
image Image Predominant polarity in bipolar disorder (BD) refers to the dominance of either depressive or manic episodes in an individual’s illness history.
Predominant Polarity in Bipolar Disorder

Depressive predominant polarity is typically defined as having at least two-thirds of lifetime episodes being depressive, whereas manic predominant polarity refers to at least two-thirds of prior episodes being (hypo)manic episodes. Studies show that predominant polarity has prognostic value and clinical and therapeutic implications.

05.02.2024 Mental Health